Sevelamer Hydrochloride
9 NDCs across 9 manufacturers|9 Generic,0 Brand
Sevelamer Hydrochloride is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 30, 1998, and the first generic was approved Feb 8, 2019. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient.
Sevelamer Hydrochloride is available as 9 NDCs from 9 manufacturers (9 generic, 0 brand), with NADAC prices from $0.70 to $1.05 per EA — a 51% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
9
competing in market
Price Spread
$0.70 – $1.05
per EA
7d Activity
avg -1.0% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
NorthStar Rx LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Phosphate Binder class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing SEVELAMER HYDROCHLORIDE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SEVELAMER HCL 800 MG TABLET | $1.0471 per EA | — |
SEVELAMER HCL 800 MG TABLET | $0.7735 per EA | — |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
SEVELAMER HCL 800 MG TABLET | $0.6952 per EA | -1.04% |
Frequently Asked Questions
What is Sevelamer Hydrochloride used to treat?
Sevelamer Hydrochloride is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
When did Sevelamer Hydrochloride become available as a generic?
FDA approved the first generic Sevelamer Hydrochloride (ANDA) on Feb 8, 2019. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Sevelamer Hydrochloride products are on the market?
The Sevelamer Hydrochloride drug market contains 9 NDCs from 9 manufacturers — 9 generic and 0 brand products.
What is the price range for Sevelamer Hydrochloride?
NADAC reference prices for Sevelamer Hydrochloride range from $0.6952 to $1.0471 per EA — a 51% difference between cheapest and most expensive.
Which manufacturers make Sevelamer Hydrochloride?
9 manufacturers list Sevelamer Hydrochloride in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (1), Sanofi-Aventis U.S. LLC (1), Aurobindo Pharma Limited (1), American Health Packaging (1), Major Pharmaceuticals (1).
How has the price of Sevelamer Hydrochloride changed recently?
Over the past 7 days, 0 Sevelamer Hydrochloride NDCs rose and 7 fell, with a market-wide average change of -1.0%.